$80,000 of NUTRIEN US LLC lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"All aspects of agricultural issues including Farm Bill Reauthorization, ethanol, critical minerals, sustainability policy, pesticide policy, and fertilizer policy. Agricultural and cross-border trade with Canada including tariffs."
You can find more data on corporate lobbying on Quiver Quantitative.
NTR Congressional Stock Trading
Members of Congress have traded $NTR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NTR stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
NTR Hedge Fund Activity
We have seen 286 institutional investors add shares of NTR stock to their portfolio, and 288 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ROYAL BANK OF CANADA removed 4,884,296 shares (-13.1%) from their portfolio in Q2 2025, for an estimated $284,461,399
- JPMORGAN CHASE & CO removed 4,467,271 shares (-63.9%) from their portfolio in Q2 2025, for an estimated $260,173,863
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 3,900,755 shares (+48.5%) to their portfolio in Q2 2025, for an estimated $227,179,971
- CAPITAL INTERNATIONAL INVESTORS added 3,512,104 shares (+181.8%) to their portfolio in Q2 2025, for an estimated $204,544,936
- TORONTO DOMINION BANK removed 2,906,862 shares (-56.4%) from their portfolio in Q2 2025, for an estimated $169,295,642
- SILCHESTER INTERNATIONAL INVESTORS LLP removed 2,866,554 shares (-27.0%) from their portfolio in Q2 2025, for an estimated $166,948,104
- BOSTON PARTNERS added 2,582,689 shares (+inf%) to their portfolio in Q2 2025, for an estimated $150,415,807
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NTR Analyst Ratings
Wall Street analysts have issued reports on $NTR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Securities issued a "Buy" rating on 08/11/2025
- B of A Securities issued a "Buy" rating on 05/14/2025
- Oppenheimer issued a "Outperform" rating on 05/13/2025
- RBC Capital issued a "Outperform" rating on 05/12/2025
- Goldman Sachs issued a "Sell" rating on 05/09/2025
To track analyst ratings and price targets for NTR, check out Quiver Quantitative's $NTR forecast page.
NTR Price Targets
Multiple analysts have issued price targets for $NTR recently. We have seen 13 analysts offer price targets for $NTR in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Richard Garchitorena from Wells Fargo set a target price of $65.0 on 10/16/2025
- Matthew DeYoe from B of A Securities set a target price of $67.0 on 10/14/2025
- Michael Tupholme from TD Securities set a target price of $72.0 on 08/11/2025
- Ben Isaacson from Scotiabank set a target price of $60.0 on 08/11/2025
- Eric Beaumont from UBS set a target price of $63.0 on 08/07/2025
- Kristen Owen from Oppenheimer set a target price of $65.0 on 07/15/2025
- Laurence Alexander from Jefferies set a target price of $66.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
